The largest study to date to analyse millions of both genetic and patient records on the long-term health conditions of later life has identified opportunities for new ways to prevent and treat ...
Dozens of demonstrators protested in front of Children’s Hospital Los Angeles Thursday evening after the hospital paused ...
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc.
Children's Hospital Los Angeles has reportedly paused the initiation of hormone therapy for new transgender youth patients. According to a report from the Los Angeles Times, the move means there will ...
Children’s Hospital Los Angeles, a major provider of care for transgender youth, says it is pausing the initiation of ...